S. Nicholson

发表

The introduction of radioactive seed localisation improves the oncological outcome of image guided breast conservation surgery.

J. O'donoghue, A. Critchley, G. Petrides, 2017, Breast.

Pre-operative staging of the axilla in primary breast cancer. By redefining the abnormal appearing node can we reduce investigations without affecting overall treatment?

L. Mclean, S. Nicholson, S. Amonkar, 2013, Breast.

Radioactive seed localization compared with wire-guided localization of non-palpable breast carcinoma in breast conservation surgery- the first experience in the United Kingdom.

J. O'donoghue, T. Lennard, A. Critchley, 2018, The British journal of radiology.

Comparison of radioligand assay and immunostaining for epidermal growth factor receptor in human breast cancer

J. Farndon, D. Hastrich, J. Dunn, 1994, The British journal of surgery.

Quantitative assays of epidermal growth factor receptor in human breast cancer: Cut‐off points of clinical relevance

A. Harris, P. Chambers, J. Sainsbury, 1988, International journal of cancer.

Will screening for breast cancer reduce mortality? Evidence from the first year of screening in Avon.

J. Farndon, A. Webb, J. D. Davies, 1993, Annals of the Royal College of Surgeons of England.

Fat-suppression magnetic resonance imaging in the preoperative localization of parathyroid adenomas.

E. Davies, J. Farndon, P. Goddard, 1992, Clinical radiology.

Natural history of the benign breast lump

V. Wadehra, J. Sainsbury, S. Nicholson, 1988, The British journal of surgery.

EPIDERMAL GROWTH-FACTOR RECEPTOR - A MARKER OF EARLY RELAPSE IN BREAST-CANCER AND TUMOR STAGE PROGRESSION IN BLADDER-CANCER - INTERACTIONS WITH NEU

D. Neal, A. Harris, J. Sainsbury, 1989 .

Epidermal Growth Factor Receptors and Breast Cancer

A. Harris, J. Sainsbury, Farndon, 1989, Bristol medico-chirurgical journal.

Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu.

J. Farndon, A. Harris, J. Sainsbury, 1989, Journal of steroid biochemistry.

ASSOCIATION OF C-ERBB-2 ONCOPROTEIN EXPRESSION WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST-CANCER

J. Cairns, B. Angus, W. Gullick, 1989 .

Relationship of membrane-bound tissue type and urokinase type plasminogen activators in human breast cancers to estrogen and epidermal growth factor receptors.

B. Angus, A. Harris, Farndon, 1988, Cancer research.

pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response.

N. Piggott, J. Henry, U. Mallick, 1991, British Journal of Cancer.

Relationships between oestrogen receptor, epidermal growth factor receptor, ER‐D5, and P24 oestrogen regulated protein in human breast cancer

A. Harris, B. Angus, C. Horne, 1988, The Journal of pathology.

Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study

S. Cawthorn, P. Williamson, R. Macmillan, 2019, The Lancet. Oncology.

EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER

J. Farndon, J. Sainsbury, P. Chambers, 1989, The Lancet.

Prognostic significance of the estrogen‐regulated protein, cathepsin D, in breast cancer. An immunohistochemical study

J. Cairns, B. Angus, C. Horne, 1990, Cancer.

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

B Angus, J. Cairns, A. Harris, 1989, Cancer research.

Synthetic oligonucleotides as therapeutic agents.

J. Farndon, B. Angus, A. Harris, 1991, British Journal of Cancer.

Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.

G. Ball, S. Lakhani, S. Pinder, 2018, European journal of cancer.

Epidermal growth factor receptors in human breast cancer.

A. Harris, S. Nicholson, 1988, Cancer treatment and research.

Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer.

B. Angus, A. Harris, P. Chambers, 1988, British Journal of Cancer.

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.

J. Cairns, B. Angus, C. Horne, 1992, British Journal of Cancer.

Use of fine needle aspiration cytology with immediate reporting in the diagnosis of breast disease

V. Wadehra, J. Sainsbury, S. Nicholson, 1988, The British journal of surgery.

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

A. Harris, B. Angus, J. Sainsbury, 1990, The Journal of Steroid Biochemistry and Molecular Biology.

Measurement of oestrogen receptor mRNA levels in human breast tumours.

J. Henry, F. May, B. Westley, 1988, British Journal of Cancer.

Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.

J. Henry, T. Lennard, C. Hennessy, 1990, British Journal of Cancer.

Epidermal growth factor receptor status of histological sub-types of breast cancer.

B. Angus, A. Harris, J. Sainsbury, 1988, British Journal of Cancer.

The varicose vein waiting list: results of a validation exercise.

J. Farndon, S. Nicholson, S. Brewster, 1991, Annals of the Royal College of Surgeons of England.

Epidermal growth factor receptor determination on tumour imprints.

J. Farndon, D. Hastrich, N. Rooney, 1993, Journal of clinical pathology.

Edinburgh trial of screening for breast cancer

P. Donnan, R. Prescott, F. Alexander, 1990, The Lancet.

Epidermal growth factor receptor and other oncogenes as prognostic markers.

A. Harris, A L Harris, S Nicholson, 1992, Journal of the National Cancer Institute. Monographs.

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.

J. Cairns, B. Angus, C. Horne, 1992, British Journal of Cancer.